Webinar Date and Time: Wednesday, November 16, 2022 4:00 – 5:00 pm EST
In the second educational webinar, Dr. Michael Crump from Princess Margaret Hospital will cover what bispecific antibodies are and how this novel therapy can help lymphoma patients across Canada. This talk will highlight who is eligible for bispecific antibody therapy and the clinical trials available for lymphoma patients in Canada.
Speakers:Dr. Michael Crump
Speaker Biographies:
Dr. Michael Crump
Michael Crump is a hematologist in the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre, and Professor of Medicine at the University of Toronto. His clinical and research interests are primary and second line therapy of lymphoid malignancies, investigation of novel therapies and in autologous stem cell transplantation. He is currently the Co-Chair of the Hematology Disease Site Group and the Lymphoma Working Group Chair for the Canadian Cancer Trials Group (CCTG).
